Amanote Research
Register
Sign In
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib
Yearbook of Pulmonary Disease
doi 10.1016/s8756-3452(08)70091-4
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2006
Authors
Unknown
Publisher
Elsevier BV
Related search
Somatic Mutations of the Epidermal Growth Factor Receptor and Non-Small-Cell Lung Cancer
Journal of Medical Genetics
Genetics
Association of Epidermal Growth Factor Receptor Mutations With Metastatic Presentations in Non-Small Cell Lung Cancer
ISRN Oncology
The Role of Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer
Dicle Medical Journal / Dicle Tip Dergisi
Enhancement of Epidermal Growth Factor Receptor-Degradation Pathway in Acquired Gefitinib-Resistant Human Non-Small Cell Lung Cancer Cell Lines
The Showa University Journal of Medical Sciences
OA14 Phase 2 Study: Tepotinib + Gefitinib in MET+/Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Epidermal Growth Factor Receptor Mutations: Effect on Volume Doubling Time of Non–Small-Cell Lung Cancer Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Chemotherapy-Induced Epidermal Growth Factor Receptor Activation Determines Response to Combined Gefitinib/Chemotherapy Treatment in Non-Small Cell Lung Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations: A Prospective Study
Biomedical Journal
Medicine
Frequency and Type of Epidermal Growth Factor Receptor Mutations in African Americans With Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
